David W Golde

Sloan-Kettering Institute For Cancer Res

$3,118,085

Attributed

$3,118,085

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$9,845,735 · 5

By mechanism

P01$6,916,285 · 2

R01$1,490,614 · 1

P30$1,438,836 · 2

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Miguel-Angel Perales$7,415,804
Nai-Kong V Cheung$9,578,208
James W. Young$11,235,643
David R Spriggs$13,987,182
Richard J O'Reilly$17,498,839

Others in their field

Top investigators on “Human Therapy Evaluation”

Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
Barbara Driver · Westat, Inc.$206,347,735
Carol Nesel · Westat$188,148,170
Constance Ann Benson · University Of California, San Diego$179,950,251

Research focus

Human Therapy EvaluationClinical TrialsHuman DataCancer PreventionColony Stimulating FactorNeoplasm /Cancer ChemotherapyHematopoietic Stem CellsStatistics /BiometryAscorbateGrowth Factor ReceptorsCell Growth RegulationChemopreventionBiological Signal TransductionClinical ResearchGlucose MetabolismHealth Science Research Analysis /EvaluationHexosesBinding SitesBiomedical ResourceHematopoiesisHealth Care Service EvaluationGlucose TransportBiomedical FacilityHealth Care Service Planning